PGC-1α is known to enhance mitochondrial function and antioxidant responses, yet overexpression increased susceptibility to MPTP-induced neuronal death. This contradicts the expected neuroprotective role and challenges PGC-1α as a therapeutic target in PD.
Gap type: contradiction
Source paper: Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf. (2012, PloS one, PMID:23145024)
Landscape Summary:
Why does PGC-1α overexpression paradoxically increase MPTP toxicity despite enhancing antioxidant defenses? is a 0.89 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?